SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-19-000909
Filing Date
2019-02-14
Accepted
2019-02-14 07:55:18
Documents
7
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_021419.htm 6-K 11000
2 EXHIBIT 99.1 exh_991.htm EX-99.1 352398
3 EXHIBIT 99.2 exh_992.htm EX-99.2 482343
4 EXHIBIT 99.3 exh_993.htm EX-99.3 9705
5 EXHIBIT 99.4 exh_994.htm EX-99.4 9802
6 GRAPHIC logo.jpg GRAPHIC 50295
7 GRAPHIC exh991p13.jpg GRAPHIC 44652
  Complete submission text file 0001171843-19-000909.txt   997175
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 19600851
SIC: 2834 Pharmaceutical Preparations